• 2022
  Azevedo R, Jacquemin C, Villain N, Fenaille F, Lamari F, Becher F, , Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications., Cells 2022 Apr; 11(8): .
• 2022
  Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, Brandão A, Fernandes E, Azevedo R, Palmeira C, Freitas R, Miranda A, Osório H, Prieto J, Lima L, Silva AMN, Santos LL, Ferreira JA, , Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion., Theranostics 2022 ; 12(7): 3150-3177.
• 2021
  Peixoto A, Ferreira D, Azevedo R, Freitas R, Fernandes E, Relvas-Santos M, Gaiteiro C, Soares J, Cotton S, Teixeira B, Paulo P, Lima L, Palmeira C, Martins G, Oliveira MJ, Silva AMN, Santos LL, Ferreira JA, , Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer., J Exp Clin Cancer Res 2021 Jun; 40(1): 191.
• 2021
  Cotton S, Ferreira D, Soares J, Peixoto A, Relvas-Santos M, Azevedo R, Piairo P, Diéguez L, Palmeira C, Lima L, Silva AMN, Lara Santos L, Ferreira JA, , Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness., Int J Mol Sci 2021 Feb; 22(4): .
• 2020
  Fernandes E, Freitas R, Ferreira D, Soares J, Azevedo R, Gaiteiro C, Peixoto A, Oliveira S, Cotton S, Relvas-Santos M, Afonso LP, Palmeira C, Oliveira MJ, Ferreira R, Silva AMN, Lara Santos L, Ferreira JA, , Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells., Cancers (Basel) 2020 Apr; 12(4): .
• 2019
  Neves M, Azevedo R, Lima L, Oliveira MI, Peixoto A, Ferreira D, Soares J, Fernandes E, Gaiteiro C, Palmeira C, Cotton S, Mereiter S, Campos D, Afonso LP, Ribeiro R, Fraga A, Tavares A, Mansinho H, Monteiro E, Videira PA, Freitas PP, Reis CA, Santos LL, Dieguez L, Ferreira JA, , Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications., N Biotechnol 2019 Mar; 49(): 77-87.
• 2019
  Peixoto A, Relvas-Santos M, Azevedo R, Santos LL, Ferreira JA, , Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks., Front Oncol 2019 ; 9(): 380.
• 2018
  Azevedo R, Soares J, Gaiteiro C, Peixoto A, Lima L, Ferreira D, Relvas-Santos M, Fernandes E, Tavares A, Cotton S, Daniel-da-Silva AL, Santos LL, Vitorino R, Amado F, Ferreira JA, , Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer., Talanta 2018 Jul; 184(): 347-355.
• 2018
  Azevedo R, Soares J, Peixoto A, Cotton S, Lima L, Santos LL, Ferreira JA, , Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology., Urol Oncol 2018 May; 36(5): 221-236.
• 2018
  Azevedo R, Silva AMN, Reis CA, Santos LL, Ferreira JA, , In silico approaches for unveiling novel glycobiomarkers in cancer., J Proteomics 2018 Jan; 171(): 95-106.
• 2018
  Azevedo R, Gaiteiro C, Peixoto A, Relvas-Santos M, Lima L, Santos LL, Ferreira JA, , CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications., Clin Proteomics 2018 ; 15(): 22.
• 2017
  Lima L, Neves M, Oliveira MI, Dieguez L, Freitas R, Azevedo R, Gaiteiro C, Soares J, Ferreira D, Peixoto A, Fernandes E, Montezuma D, Tavares A, Ribeiro R, Castro A, Oliveira M, Fraga A, Reis CA, Santos LL, Ferreira JA, , Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases., Urol Oncol 2017 Dec; 35(12): 675.e1-675.e8.
• 2017
  Azevedo R, Peixoto A, Gaiteiro C, Fernandes E, Neves M, Lima L, Santos LL, Ferreira JA, , Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?, Oncotarget 2017 Oct; 8(53): 91734-91764.
• 2017
  Cotton S, Azevedo R, Gaiteiro C, Ferreira D, Lima L, Peixoto A, Fernandes E, Neves M, Neves D, Amaro T, Cruz R, Tavares A, Rangel M, Silva AMN, Santos LL, Ferreira JA, , Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours., Mol Oncol 2017 Aug; 11(8): 895-912.
• 2016
  Lima A, Bernardes M, Azevedo R, Seabra V, Medeiros R, , Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome., Pharmacogenomics 2016 Oct; 17(15): 1649-1674.
• 2016
  Peixoto A, Fernandes E, Gaiteiro C, Lima L, Azevedo R, Soares J, Cotton S, Parreira B, Neves M, Amaro T, Tavares A, Teixeira F, Palmeira C, Rangel M, Silva AM, Reis CA, Santos LL, Oliveira MJ, Ferreira JA, , Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension., Oncotarget 2016 Sep; 7(39): 63138-63157.
• 2015
  Azevedo R, Bernardes M, Fonseca J, Lima A, , Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs., Rheumatol Int 2015 Oct; 35(10): 1675-85.
• 2015
  Azevedo R, Ferreira JA, Peixoto A, Neves M, Sousa N, Lima A, Santos LL, , Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review., J Control Release 2015 Sep; 214(): 40-61.
• 2015
  Lima A, Bernardes M, Azevedo R, Medeiros R, Seabra V, , Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?, Int J Mol Sci 2015 Jun; 16(6): 13760-80.
• 2015
  Azevedo AR, de Sousa HM, Monteiro JA, Lima AR, , Future perspectives of Smartphone applications for rheumatic diseases self-management., Rheumatol Int 2015 Mar; 35(3): 419-31.
• 2014
  Lima A, Bernardes M, Azevedo R, Monteiro J, Sousa H, Medeiros R, Seabra V, , SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients., Toxicol Sci 2014 Nov; 142(1): 196-209.
• 2014
  Lima A, Bernardes M, Sousa H, Azevedo R, Costa L, Ventura F, Seabra V, Medeiros R, , SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients., Pharmacogenomics 2014 Apr; 15(6): 807-20.
• 2014
  Lima A, Seabra V, Bernardes M, Azevedo R, Sousa H, Medeiros R, , Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients., PLoS One 2014 ; 9(10): e108165.
• 2014
  Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, Medeiros R, , Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms., Biomed Res Int 2014 ; 2014(): 368681.
• 2014
  Lima A, Sousa H, Monteiro J, Azevedo R, Medeiros R, Seabra V, , Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers., Pharmacogenomics 2014 ; 15(12): 1611-35.
• 2013
  Lima A, Azevedo R, Sousa H, Seabra V, Medeiros R, , Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics., Pharmacogenomics 2013 Aug; 14(11): 1337-51.